Is medial arterial (Mönckeberg) calcification of the foot associated with AL (light‑chain) amyloidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medial Arterial Calcification and AL Amyloidosis

No, medial arterial (Mönckeberg) calcification of the foot is not associated with AL (light-chain) amyloidosis. Mönckeberg sclerosis occurs predominantly in patients with diabetes mellitus, chronic kidney disease, advanced age, and following sympathetic denervation—not in AL amyloidosis. 1, 2

Established Causes of Mönckeberg Calcification

The evidence clearly identifies specific populations at risk for medial arterial calcification:

  • Diabetes mellitus with peripheral neuropathy: Medial calcification is frequently seen in diabetic patients with severe neuropathy, where it can interfere with ankle-brachial index (ABI) measurements by producing falsely elevated readings (ABI >1.40). 1

  • Chronic kidney disease: Medial calcification develops in most patients as they transition to significant CKD, representing accelerated atherosclerosis with osteoblastic transformation of vascular smooth muscle cells. 3

  • Sympathetic denervation: In a study of 60 patients (19 diabetic, 41 non-diabetic) examined 6-8 years after lumbar sympathectomy, 92% developed medial calcification—occurring regardless of diabetes status. After unilateral sympathectomy, calcification occurred on the operated side in 88% versus only 18% on the contralateral side. 4

  • Advanced age: Medial calcification occurs commonly in aged individuals as part of the natural aging process. 5

AL Amyloidosis: Distinct Vascular Pathology

AL amyloidosis causes a completely different pattern of vascular involvement:

  • Amyloid protein deposits in coronary vessel walls: The amyloid deposits occur in the media and adventitia of coronary arteries and veins, potentially causing cardiac ischemia—but this is protein deposition, not calcium phosphate precipitation. 1

  • No association with medial calcification: None of the comprehensive guidelines on AL amyloidosis diagnosis 6, treatment 7, or clinical manifestations 8 mention medial arterial calcification as a feature of the disease.

Clinical Distinction and Diagnostic Implications

When evaluating a patient with medial calcification on foot radiographs:

  • First, assess for diabetes and neuropathy: Peripheral neuropathy associated with diabetes is the most common cause of medial wall calcification (Mönckeberg sclerosis), which produces rigid arteries and elevated ABI readings. 1

  • Second, evaluate renal function: Check for chronic kidney disease, as CKD is strongly associated with accelerated medial calcification through phosphorus-mediated osteoblastic transformation of vascular smooth muscle cells. 3

  • Do not pursue AL amyloidosis workup based on calcification alone: The presence of medial calcification should not trigger evaluation for AL amyloidosis unless the patient has other cardinal features such as restrictive cardiomyopathy, nephrotic-range proteinuria, peripheral neuropathy with autonomic features, or macroglossia. 6

Radiographic Differentiation

Medial calcification has characteristic radiographic features that distinguish it from intimal atherosclerotic calcification:

  • Regular and diffuse pattern: Medial calcification appears as regular, linear "railroad track" calcification along arterial walls, correctly identified in 92% of cases by radiographic criteria. 9

  • No physiologic stenosis: Unlike intimal calcific atherosclerosis, medial calcification does not necessarily cause arterial stenosis or reduced blood flow, though it does increase arterial stiffness. 1, 9

Common Pitfall to Avoid

Do not confuse the renal manifestations of AL amyloidosis with the renal disease that causes medial calcification. While AL amyloidosis causes nephrotic syndrome with proteinuria in approximately 70% of patients 8, this is due to amyloid deposition in glomeruli—not the chronic kidney disease that drives medial calcification through mineral metabolism derangements. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Medial Arterial Calcification: JACC State-of-the-Art Review.

Journal of the American College of Cardiology, 2021

Guideline

Diagnostic Work‑Up for Suspected AL Amyloidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Light-Chain (AL) Amyloidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clinical Manifestations of Renal Amyloidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What does medial arterial calcification (Monckeberg sclerosis) of the small foot arteries indicate and how should it be evaluated and managed?
What is the management approach for Mediocalcinosis (Medial Calcific Sclerosis), a condition characterized by vascular calcification?
In a 28‑year‑old man with a one‑week history of intermittent frontal and occipital squeezing headache lasting 10–15 minutes, brief orthostatic dizziness with transient visual darkening on standing, undocumented fever, symptom relief with paracetamol (acetaminophen) and sleep, and normal vital signs and physical examination, what is the most likely diagnosis and appropriate next steps in management?
What should be included in a discharge summary (patient age, sex, admission date, primary admission diagnosis, comorbidities, hospital course, investigations, procedures, complications, discharge diagnoses, medication list with dose/route/frequency and changes, follow‑up appointments, recommended labs/imaging, criteria for urgent return, patient education, and discharging clinician’s name/contact)?
What are the typical presentation, diagnostic work‑up, classification, and management (including indications for liver transplantation versus shunt closure) of congenital extra‑hepatic portosystemic shunt (Abernethy malformation) in children and young adults?
What antipsychotic is most evidence‑based and well‑tolerated for augmenting fluoxetine in an adult with major depressive disorder who has not responded after at least 6–8 weeks of ≥20 mg daily fluoxetine?
What are the clinical uses, recommended dosing, and safety profile of glutathione supplementation?
What is the recommended workup for an unvaccinated 6‑month‑old infant presenting with three days of fever and acute otitis media?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.